Endo Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO PHARM, and what generic alternatives to ENDO PHARM drugs are available?
ENDO PHARM has twenty-one approved drugs.
There are nineteen US patents protecting ENDO PHARM drugs.
There are two hundred and fifty-three patent family members on ENDO PHARM drugs in forty-two countries and three supplementary protection certificates in three countries.
Summary for Endo Pharm
International Patents: | 253 |
US Patents: | 19 |
Tradenames: | 18 |
Ingredients: | 15 |
NDAs: | 21 |
Patent Litigation for Endo Pharm: | See patent lawsuits for Endo Pharm |
PTAB Cases with Endo Pharm as petitioner: | See PTAB cases with Endo Pharm as petitioner |
PTAB Cases with Endo Pharm as patent owner: | See PTAB cases with Endo Pharm as patent owner |
Drugs and US Patents for Endo Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-001 | Jun 22, 2006 | DISCN | Yes | No | 8,871,779 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-003 | Dec 9, 2011 | DISCN | Yes | No | 8,871,779 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-001 | Dec 9, 2011 | DISCN | Yes | No | 8,871,779 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610-002 | Jun 22, 2006 | DISCN | Yes | No | 8,808,737 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Endo Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | 7,404,489 | ⤷ Try a Trial |
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-004 | Dec 9, 2011 | 8,329,216 | ⤷ Try a Trial |
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-001 | Dec 9, 2011 | 8,309,122 | ⤷ Try a Trial |
Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-003 | Dec 9, 2011 | 8,075,872 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ENDO PHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 250 mg/mL | ➤ Subscribe | 2014-06-11 |
➤ Subscribe | Gel | 10 mg/actuation | ➤ Subscribe | 2012-08-14 |
➤ Subscribe | Extended-release Tablets | 7.5 mg and 15 mg | ➤ Subscribe | 2008-05-29 |
➤ Subscribe | Tablets | 2.5 mg | ➤ Subscribe | 2011-03-09 |
➤ Subscribe | Nasal Spray | 500 mcg/spray | ➤ Subscribe | 2017-04-28 |
➤ Subscribe | Extended-release Tablets | 5 mg, 10 mg, 20 mg and 40 mg | ➤ Subscribe | 2007-11-23 |
➤ Subscribe | Extended-release Tablets | 30 mg | ➤ Subscribe | 2008-06-12 |
International Patents for Endo Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2006002883 | ⤷ Try a Trial |
South Korea | 101299928 | ⤷ Try a Trial |
European Patent Office | 1494649 | ⤷ Try a Trial |
Mexico | 2008000396 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Endo Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0591280 | SPC/GB03/014 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 3 METHYLAMINO-6-CARBOXAMIDO-1, 2, 3, 4-TETRAHYDROCARBAZOLE ("FROVATRIPTAN") INCLUDING A SALT, SOLVATE OR HYDRATE THEREOF; REGISTERED: FR NL 24548 20001212; UK PL 16239/0017 20021007; UK PL 16239/0018 20021007 |
0591280 | C300103 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPTAN EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 27211RVG 27212 2002190419; FIRST REGISTRATION: NL 24548 20001212 |
0591280 | 01C0019 | France | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPTAN SUCCINATE MONOHYDRATE; NAT. REGISTRATION NO/DATE: NL 24548 20001212; FIRST REGISTRATION: FR - NL 24548 20001212 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.